Environmental/Airborne Allergy News

Healio compiled the most-read news in allergy, asthma and immunology posted in September.

An FDA advisory panel has deemed oral phenylephrine, an ingredient in many cold and allergy medications sold over the counter to treat decongestion, no more effective than placebo.

An FDA panel voted unanimously against the efficacy of oral phenylephrine, an ingredient in many nasal decongestants sold over the counter to treat colds and allergy symptoms.

Healio compiled the most-read news in allergy, asthma and immunology posted in August.

Adults with late allergic responses to birch experienced IL-13 responses that correlated with cytokine and clinical responses to provocation, according to a study published in The Journal of Allergy and Clinical Immunology.

PARK CITY, Utah — Patients with asthma and allergies exacerbated by mold and mildew can be proactive in mitigating their effects at home, according to a presentation here.

PARK CITY, Utah — Bee stings and a good night’s rest were on the agenda, among other topics, during the second day of the Association of PAs in Allergy, Asthma and Immunology Annual Allergy, Asthma & Immunology CME Conference.

As hundreds of wildfires in Canada drive haze and smoke across the East Coast, patients and providers alike may worry about the effect on their health, including asthma and other illnesses.

As allergies emerge each spring, so do migraines. The American Migraine Foundation says that 37% of people with allergies also have migraines, compared with 5% of people who do not have allergies, in an association that increases with age.

Only about one-third of patients adhered to their course of maintenance doses in their subcutaneous immunotherapy even when there were no out-of-pocket expenses, according to a study published in Annals of Allergy, Asthma & Immunology.